Varex Imaging (NASDAQ:VREX) Earns "Sell (D)" Rating from Weiss Ratings

Key Points

• Varex Imaging's stock has been given a "sell (D)" rating by Weiss Ratings, while B. Riley has raised its price target from $12.00 to $16.00 and maintained a "buy" rating.
• The company recently reported earnings of $0.18 per share, surpassing analysts' expectations of $0.04, along with revenue of $203 million against estimates of $190.32 million.
• Varex Imaging's stock trades around $11.77, having a market cap of approximately $488.46 million and a 200-day moving average of $9.26.

Varex Imaging (NASDAQ:VREX - Get Free Report)'s stock had its "sell (d)" rating reissued by equities researchers at Weiss Ratings in a research note issued to investors on Wednesday,Weiss Ratings reports.

Several other equities analysts have also weighed in on the stock. B. Riley restated a "buy" rating and set a $16.00 price objective (up previously from $12.00) on shares of Varex Imaging in a research report on Friday, August 8th. Wall Street Zen cut shares of Varex Imaging from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 9th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $19.50.

Varex Imaging Price Performance

VREX traded up $0.21 on Wednesday, reaching $11.77. The company had a trading volume of 278,235 shares, compared to its average volume of 451,537. The company has a fifty day moving average of $10.99 and a 200-day moving average of $9.26. The company has a market capitalization of $488.46 million, a P/E ratio of -3.67 and a beta of 0.96. The company has a current ratio of 3.51, a quick ratio of 1.82 and a debt-to-equity ratio of 0.78. Varex Imaging has a one year low of $6.76 and a one year high of $16.93.

Varex Imaging (NASDAQ:VREX - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.04 by $0.14. The firm had revenue of $203.00 million during the quarter, compared to analyst estimates of $190.32 million. Varex Imaging had a negative net margin of 16.13% and a positive return on equity of 5.54%. Varex Imaging has set its Q4 2025 guidance at 0.100-0.300 EPS. As a group, equities research analysts anticipate that Varex Imaging will post 0.53 earnings per share for the current year.

Institutional Trading of Varex Imaging

A number of hedge funds have recently made changes to their positions in the stock. The Manufacturers Life Insurance Company lifted its position in shares of Varex Imaging by 10.4% in the second quarter. The Manufacturers Life Insurance Company now owns 15,302 shares of the company's stock worth $133,000 after purchasing an additional 1,442 shares in the last quarter. LSV Asset Management lifted its position in shares of Varex Imaging by 0.5% in the second quarter. LSV Asset Management now owns 328,610 shares of the company's stock worth $2,849,000 after purchasing an additional 1,631 shares in the last quarter. BNP Paribas Financial Markets lifted its position in shares of Varex Imaging by 18.5% in the second quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company's stock worth $113,000 after purchasing an additional 2,036 shares in the last quarter. Nebula Research & Development LLC raised its position in Varex Imaging by 11.0% during the second quarter. Nebula Research & Development LLC now owns 22,795 shares of the company's stock valued at $198,000 after acquiring an additional 2,250 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC raised its position in Varex Imaging by 25.5% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 13,104 shares of the company's stock valued at $115,000 after acquiring an additional 2,659 shares in the last quarter.

Varex Imaging Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.